Anxiolytic-like effects of extremely low frequency electric field in stressed rats: involvement of 5-HT2C receptors

References

• Alves SH, Pinheiro G, Motta V, Landeira-Fernandez J, Cruz AP. 2004. Anxiogenic effects in the rat elevated plus-maze of 5-HT(2C) agonists into ventral but not dorsal hippocampus. Behav Pharmacol. 15(1):37–43.
   PubMed Web of Science ®Google Scholar
• Basar E, Duzgun A. 2016. How is the brain working?: Research on brain oscillations and connectivities in a new “Take-Off” state. Int J Psychophysiol. 103:3–11.
   PubMed Web of Science ®Google Scholar
• Berger J, Heinrichs M, von Dawans B, Way BM, Chen FS. 2016. Cortisol modulates men’s affiliative responses to acute social stress. Psychoneuroendocrinology. 63:1–9.
   PubMed Web of Science ®Google Scholar
• Buchanan TW, Preston SD. 2014. Stress leads to prosocial action in immediate need situations. Front Behav Neurosci. 8:5.
   PubMed Web of Science ®Google Scholar
• Bull EJ, Hutson PH, Fone KCF. 2003. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT2C receptor responsivity. Neuropharmacology. 44(4):439–448.
   PubMed Web of Science ®Google Scholar
• Chakraborty P, Datta S, McEwen BS, Chattarji S. 2020. Corticosterone after acute stress prevents the delayed effects on the amygdala. Neuropsychopharmacology. 45(13):2139–2146.
   PubMed Web of Science ®Google Scholar
• Charney DS, Woods SW, Goodman WK, Heninger GR. 1987. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl). 92(1):14–24.
   PubMed Web of Science ®Google Scholar
• Collimore KC, Carleton RN, Hofmann SG, Asmundson GJG. 2010. Posttraumatic stress and social anxiety: the interaction of traumatic events and interpersonal fears. Depress Anxiety. 27(11):1017–1026.
   PubMed Web of Science ®Google Scholar
• de Bruyn L, de Jager L. 1994. Electric field exposure and evidence of stress in mice. Environ Res. 65(1):149–160.
   PubMed Web of Science ®Google Scholar
• Dekeyne A, Denorme B, Monneyron S, Millan MJ. 2000. Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharmacology. 39(6):1114–1117.
   PubMed Web of Science ®Google Scholar
• Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E. 2000. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse. 35(1):53–61.
   PubMed Web of Science ®Google Scholar
• Filip M, Bader M. 2009. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep. 61(5):761–777.
   PubMed Web of Science ®Google Scholar
• Frick A, Åhs F, Engman J, Jonasson M, Alaie I, Björkstrand J, Frans Ö, Faria V, Linnman C, Appel L, et al. 2015. Serotonin synthesis and reuptake in social anxiety disorder: a positron emission tomography study. JAMA Psychiatry. 72(8):794–802.
   PubMed Web of Science ®Google Scholar
• Gomes F, Greidinger M, Salviano M, Couto KC, Ferreira Scaperlli G, de Sousa Alves SH, de Mello Cruz AP. 2010. Antidepressant- and anxiogenic-like effects of acute 5-HT2C receptor activation in rats exposed to the forced swim test and elevated plus maze. Psychol Neurosci. 3(2):245–249.
   Google Scholar
• Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF. 1996. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 54(1):129–141.
   PubMed Web of Science ®Google Scholar
• Harakawa S, Hori T, Inoue N, Suzuki H. 2017. Time-dependent changes in the suppressive effect of electric field exposure on immobilization-induced plasma glucocorticoid increase in mice. Bioelectromagnetics. 38(4):272–279.
   PubMed Web of Science ®Google Scholar
• Harakawa S, Takahashi I, Doge F, Martin DE. 2004. Effect of a 50 Hz electric field on plasma ACTH, glucose, lactate, and pyruvate levels in stressed rats. Bioelectromagnetics. 25(5):346–351.
   PubMed Web of Science ®Google Scholar
• Heisler LK, Zhou L, Bajwa P, Hsu J, Tecott LH. 2007. Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav. 6(5):491–496.
   PubMed Web of Science ®Google Scholar
• Herrero AI, Sandi C, Venero C, 2006. Individual differences in anxiety trait are related to spatial learning abilities and hippocampal expression of mineralocorticoid receptors. Neurobiol Learn Mem. 86(2):150–159.
   PubMed Web of Science ®Google Scholar
• Hilt RJ, Chaudhari M, Bell JF, Wolf C, Koprowicz K, King BH. 2014. Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents. J Child Adol Psychop. 24(2):83–89.
   PubMed Web of Science ®Google Scholar
• Homberg JR, Contet C. 2009. Deciphering the interaction of the corticotropin-releasing factor and serotonin brain systems in anxiety-related disorders. J Neurosci. 29(44):13743–13745.
   PubMed Web of Science ®Google Scholar
• Hori T, Inoue N, Suzuki H, Harakawa S. 2015. Exposure to 50 Hz electric fields reduces stress-induced glucocorticoid levels in BALB/c mice in a kV/m- and duration-dependent manner. Bioelectromagnetics. 36(4):302–308.
   PubMed Web of Science ®Google Scholar
• Jones N, Duxon MS, King SM. 2002. 5-HT2c receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze. Psychopharmacology (Berl). 164(2):214–220.
   PubMed Web of Science ®Google Scholar
• Jorgensen H, Knigge U, Kjaer A, Vadsholt T, Warberg J. 1998. Serotonergic involvement in stress-induced ACTH release. Brain Res. 811(1–2):10–20.
   PubMed Web of Science ®Google Scholar
• Kendler KS. 2016. The phenomenology of major depression and the representativeness and nature of DSM criteria. Am J Psychiatry. 173(8):771–780.
   PubMed Web of Science ®Google Scholar
• Klaassen T, Riedel WJ, van Praag HM, Menheere PP, Griez E. 2002. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Res. 113(1-2):29–40.
   PubMed Web of Science ®Google Scholar
• Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. 2008. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev. 32(6):1174–1184.
   PubMed Web of Science ®Google Scholar
• Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, et al. 2007. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry. 61(9):1081–1089.
   PubMed Web of Science ®Google Scholar
• Lapshin O, Joshi A, Finkelstein J. 2005. Perception of side effects, medication adherence and quality of life in psychiatric patients. Value Health. 8(3):398–398.
   Web of Science ®Google Scholar
• McEwen BS. 2000. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 886(1–2):172–189.
   PubMed Web of Science ®Google Scholar
• Millan MJ, Brocco M, Gobert A, Dekeyne A. 2005. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl). 177(4):448–458.
   PubMed Web of Science ®Google Scholar
• Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D. 2003. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine(2C) receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 306(3):954–964.
   PubMed Web of Science ®Google Scholar
• Mongeau R, Martin CB, Chevarin C, Maldonado R, Hamon M, Robledo P, Lanfumey L. 2010. 5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment. J Neurochem. 115(2):438–449.
   PubMed Web of Science ®Google Scholar
• Overstreet DH, Knapp DJ, Moy SS, Breese GR. 2003. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology (Berl). 167(4):344–352.
   PubMed Web of Science ®Google Scholar
• Patriquin MA, Mathew SJ. 2017. The neurobiological mechanisms of generalized anxiety disorder and chronic stress. Chronic Stress. 1:247054701770399.
   Google Scholar
• Pullar CE, Baier BS, Kariya Y, Russell AJ, Horst BAJ, Marinkovich MP, Isseroff RR. 2006. beta4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. Mol Biol Cell. 17(11):4925–4935.
   PubMed Web of Science ®Google Scholar
• Tveito M, Correll CU, Bramness JG, Engedal K, Lorentzen B, Refsum H, Hoiseth G. 2016. Correlates of major medication side effects interfering with daily performance: results from a cross-sectional cohort study of older psychiatric patients. Int Psychogeriatr. 28(2):331–340.
   PubMed Web of Science ®Google Scholar
• Van der Wee NJ, van Veen JF, Stevens H, van Vliet IM, van Rijk PP, Westenberg HG. 2008. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med. 49(5):757–763.
   PubMed Web of Science ®Google Scholar
• von Dawans B, Trueg A, Kirschbaum C, Fischbacher U, Heinrichs M. 2018. Acute social and physical stress interact to influence social behavior: The role of social anxiety. PLoS One. 13(10):e0204665.
   PubMed Web of Science ®Google Scholar
• Wutzler A, Winter C, Kitzrow W, Uhl I, Wolf RJ, Heinz A, Juckel G. 2008. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology. 33(13):3176–3181.
   PubMed Web of Science ®Google Scholar
• Wyss C, Hitz K, Hengartner MP, Theodoridou A, Obermann C, Uhl I, Roser P, Grunblatt E, Seifritz E, Juckel G, et al. 2013. The Loudness Dependence of Auditory Evoked Potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms. PLoS One. 8(7):e68650.
   PubMed Web of Science ®Google Scholar